Cargando…

The clinical and public health problem of relapse despite primaquine therapy: case review of repeated relapses of Plasmodium vivax acquired in Papua New Guinea

BACKGROUND: Primaquine is the only drug available for preventing relapse following a primary attack by Plasmodium vivax malaria. This drug imposes several important problems: daily dosing over two weeks; toxicity in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency; partner blood sch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ingram, R Joan H, Crenna-Darusallam, Chelzie, Soebianto, Saraswati, Noviyanti, Rintis, Baird, J Kevin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295472/ https://www.ncbi.nlm.nih.gov/pubmed/25495607 http://dx.doi.org/10.1186/1475-2875-13-488

Ejemplares similares

Association of Impaired Cytochrome P450 2D6 Activity Genotype and Phenotype With Therapeutic Efficacy of Primaquine Treatment for Latent Plasmodium vivax Malaria
por: Baird, J. Kevin, et al.
Publicado: (2018)

Hypnozoite depletion in successive Plasmodium vivax relapses
por: Noviyanti, Rintis, et al.
Publicado: (2022)

Plasmodium vivax Malaria Relapses after Primaquine Prophylaxis
por: Reddy, Pavani, et al.
Publicado: (2006)

Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study
por: Douglas, Nicholas M., et al.
Publicado: (2017)

Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria
por: Llanos-Cuentas, A., et al.
Publicado: (2019)

Higher-Dose Primaquine to Prevent Relapse of Plasmodium vivax Malaria
por: Watson, James A., et al.
Publicado: (2022)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
por: Setyadi, Agus, et al.
Publicado: (2019)

G6PD Deficiency at Sumba in Eastern Indonesia Is Prevalent, Diverse and Severe: Implications for Primaquine Therapy against Relapsing Vivax Malaria
por: Satyagraha, Ari Winasti, et al.
Publicado: (2015)

Efficacy of Primaquine in Preventing Short- and Long-Latency Plasmodium vivax Relapses in Nepal
por: Rijal, Komal Raj, et al.
Publicado: (2019)

Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria
por: Milligan, Rachael, et al.
Publicado: (2019)

Relapse of Plasmodium vivax and Plasmodium ovale Malaria With and Without Primaquine Treatment in a Nonendemic Area
por: Wångdahl, Andreas, et al.
Publicado: (2021)

Relapse of imported Plasmodium vivax malaria is related to primaquine dose: a retrospective study
por: Townell, Nicola, et al.
Publicado: (2012)

The Incidence and Differential Seasonal Patterns of Plasmodium vivax Primary Infections and Relapses in a Cohort of Children in Papua New Guinea
por: Ross, Amanda, et al.
Publicado: (2016)

Pharmacogene Variation in Thai Plasmodium vivax Relapse Patients Treated with a Combination of Primaquine and Chloroquine
por: Chamnanphon, Monpat, et al.
Publicado: (2020)

Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency
por: Kheng, Sim, et al.
Publicado: (2015)

Four Times of Relapse of Plasmodium vivax Malaria Despite Primaquine Treatment in a Patient with Impaired Cytochrome P450 2D6 Function
por: Choi, Sungim, et al.
Publicado: (2022)

Geographical variation in Plasmodium vivax relapse
por: Battle, Katherine E, et al.
Publicado: (2014)

Genetic Analysis of Primaquine Tolerance in a Patient with Relapsing Vivax Malaria
por: Bright, A. Taylor, et al.
Publicado: (2013)

The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia
por: Thriemer, Kamala, et al.
Publicado: (2020)

Randomized trial of primaquine hypnozoitocidal efficacy when administered with artemisinin-combined blood schizontocides for radical cure of Plasmodium vivax in Indonesia
por: Nelwan, Erni J., et al.
Publicado: (2015)

Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms
por: Baird, J. Kevin, et al.
Publicado: (2018)

Management of relapsing Plasmodium vivax malaria
por: Chu, Cindy S, et al.
Publicado: (2016)

Tafenoquine co-administered with dihydroartemisinin–piperaquine for the radical cure of Plasmodium vivax malaria (INSPECTOR): a randomised, placebo-controlled, efficacy and safety study
por: Sutanto, Inge, et al.
Publicado: (2023)

Primaquine radical cure of Plasmodium vivax: a critical review of the literature
por: John, George K, et al.
Publicado: (2012)

Therapeutic efficacy of alternative primaquine regimens to standard treatment in preventing relapses by Plasmodium vivax: A systematic review and meta-analysis
por: Zuluaga-Idarraga, Lina Marcela, et al.
Publicado: (2015)

Sustained Release Formulation of Primaquine for Prevention of Relapse of Plasmodium vivax Malaria: A Randomized, Double-Blind, Comparative, Multicentric Study
por: Pareek, Anil, et al.
Publicado: (2015)

Antirelapse Efficacy of Various Primaquine Regimens for Plasmodium vivax
por: Rajgor, D. D., et al.
Publicado: (2014)

Origins and implications of neglect of G6PD deficiency and primaquine toxicity in Plasmodium vivax malaria
por: Baird, Kevin
Publicado: (2015)

A Randomised Trial of an Eight-Week, Once Weekly Primaquine Regimen to Prevent Relapse of Plasmodium vivax in Northwest Frontier Province, Pakistan
por: Leslie, Toby, et al.
Publicado: (2008)

Multiplicity and Diversity of Plasmodium vivax Infections in a Highly Endemic Region in Papua New Guinea
por: Koepfli, Cristian, et al.
Publicado: (2011)

Determinants of relapse periodicity in Plasmodium vivax malaria
por: White, Nicholas J
Publicado: (2011)

Population heterogeneity in Plasmodium vivax relapse risk
por: Stadler, Eva, et al.
Publicado: (2022)

Several Plasmodium vivax relapses after correct primaquine treatment in a patient with impaired cytochrome P450 2D6 function
por: Martin Ramírez, Alexandra, et al.
Publicado: (2020)

The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections: a randomized, controlled trial in Lao PDR
por: Phommasone, Koukeo, et al.
Publicado: (2020)

Increased primaquine total dose prevents Plasmodium vivax relapses in patients with impaired CYP2D6 activity: report of three cases
por: de Pina-Costa, Anielle, et al.
Publicado: (2021)

Blood-Stage Parasitaemia and Age Determine Plasmodium falciparum and P. vivax Gametocytaemia in Papua New Guinea
por: Koepfli, Cristian, et al.
Publicado: (2015)

Modeling the relapse distribution of Plasmodium vivax in different geographies
por: Eckhoff, Philip, et al.
Publicado: (2014)

Tafenoquine for preventing relapse in people with Plasmodium vivax malaria
por: Rajapakse, Senaka, et al.
Publicado: (2015)

Factors associated with children’s health facility visits for primaquine treatment in rural Papua New Guinea
por: Yoshii, Akiko, et al.
Publicado: (2019)

Correction to: The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections: a randomized, controlled trial in Lao PDR
por: Phommasone, Koukeo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1v30e68c7g5uboubiou4f7qbg3